Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Podcast Summary

Introduction: Dr. Warrick Bishop, a cardiologist and CEO of the Healthy Heart Network, hosts this episode discussing low-carbohydrate and ketogenic diets with guests Dr. Tony Sangster (a type 1 diabetic for 56 years) and Dr. Karim Kostner (a lipid specialist). The episode explores how reduced-carbohydrate diets affect blood sugar control, cardiovascular health, cholesterol levels, and saturated fat intake.

Key Takeaways:

• Tony Sangster achieved remarkable blood sugar control on a low-carbohydrate diet, reducing his HbA1c from above 7 to below 5.5 (non-diabetic range) without experiencing dangerous low blood sugar episodes.

• Low-carbohydrate diets work by reducing sugar intake since carbohydrates are chemical structures that break down into sugar, directly lowering blood glucose levels in the body.

• Ketogenic diets trigger ketosis, where the body switches from burning glucose to burning fat for energy, producing ketones as an alternative fuel source with potential anti-inflammatory benefits.

• Some people on ketogenic diets experience significant increases in LDL cholesterol (up to 10-15 millimoles per liter), particularly those with genetic predispositions to absorb dietary cholesterol differently.

• Short-term LDL cholesterol increases are not immediately harmful, but long-term effects in people with sustained elevated levels remain understudied and potentially concerning for cardiovascular risk.

• Low-carbohydrate diets provide metabolic benefits including improved weight control, reduced inflammation, better insulin resistance, and improved blood pressure control.

• The approach to diet should differ based on individual risk factors: patients with diabetes or existing coronary disease require LDL-lowering medication alongside dietary modifications, while healthy individuals without disease may not need immediate pharmaceutical intervention.

• Statins are well-tolerated by 95% of patients and are recommended for those with diabetes or coronary disease, though some individuals (like Tony) experience significant side effects requiring alternative approaches.

• The distinction between saturated fat intake and LDL cholesterol is important, as saturated fat can increase LDL levels through specific metabolic mechanisms.

• Long-term longitudinal studies are needed to determine whether the benefits of reduced-carbohydrate diets outweigh potential cardiovascular risks from sustained elevated LDL cholesterol in vulnerable populations.